Moran Sean F.
Chief Financial Officer
Moran Sean F. has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Aug 10, 2026.
On the most recent filing, Moran Sean F. is listed as Chief Financial Officer at Corbus Pharmaceuticals Holdings, Inc. Inside the rolling window, Moran Sean F. reported no open-market purchases and 2 open-market sales totaling $158K in CRBP. The largest disclosed transaction in the window is a sale of 12,000 CRBP shares on Aug 7, 2026, worth $121K.
Companies traded
Other insiders at CRBP
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$158K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 24, 2025 | CRBP | Sale | $221K |
Frequently asked questions
How many SEC Form 4 filings has Moran Sean F. made?
Moran Sean F. has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Moran Sean F. trade?
Moran Sean F. has filed SEC Form 4 disclosures for 1 company, including CRBP.
When was Moran Sean F.'s most recent SEC Form 4 filing?
Moran Sean F.'s most recent SEC Form 4 filing on Tracefour is dated Aug 10, 2026.
What is Moran Sean F.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Moran Sean F. is listed as Chief Financial Officer.
What is Moran Sean F.'s total buy and sell value in the current window?
Inside the rolling retention window, Moran Sean F. bought $0 and sold $158K based on SEC Form 4 filings.
What was Moran Sean F.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 12,000 CRBP shares on 2026-08-07, worth $121K, per SEC Form 4 filings.